What is Proprio?
Proprio is at the forefront of revolutionizing healthcare by merging robotics, computer vision, machine learning, and immersive computing. The company's core mission is to enhance the synergistic performance of both human and machine within medical environments. This innovative approach aims to drive advancements in patient care, surgical procedures, and diagnostic capabilities by leveraging cutting-edge technology to augment human expertise and precision.
How much funding has Proprio raised?
Proprio has raised a total of $66M across 2 funding rounds:
Series A
$23M
Series B
$43M
Series A (2020): $23M with participation from Alan Frazier, Cota Capital, and BOLD Capital Partners
Series B (2023): $43M, investors not publicly disclosed
Key Investors in Proprio
BOLD Capital Partners
BOLD Capital Partners is an investment firm that typically backs companies with significant growth potential, often in technology and innovation sectors. Their involvement suggests a strategic alignment with Proprio's mission to advance healthcare through technology.
Cota Capital
Cota Capital is an investment firm that focuses on early-stage technology companies addressing innovative challenges in the enterprise sector. They combine financial investment with deep operational expertise and industry insights to empower founders in building transformative businesses. The firm believes that knowledge is the ultimate capital, leveraging a vast network and investment rigor to help entrepreneurs succeed. Their portfolio includes a diverse range of companies that are pioneering new technologies and solutions.
Alan Frazier
Alan Frazier, founder of East Seattle Partners and Frazier Healthcare Partners, brings extensive experience in healthcare investment. His participation indicates a strong belief in Proprio's potential to innovate within the healthcare industry.
What's next for Proprio?
With a substantial enterprise-level funding injection, Proprio is poised for accelerated growth and market expansion. The strategic investment signals strong investor confidence in the company's vision and its potential to disrupt the healthcare technology landscape. Future endeavors will likely focus on scaling its technological solutions, forging strategic partnerships within the healthcare ecosystem, and further developing its integrated human-machine performance platforms to address critical needs in medical treatment and patient outcomes.
See full Proprio company page
